Quinolinone derivatives as tyrosine kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/4709 (2006.01) A61K 31/496 (2006.01) A61P 35/00 (2006.01) C07D 401/04 (2006.01)

Patent

CA 2421120

Organic compounds having the formulas I and II are provided [SEE FORMULA I] [SEE FORMULA II] where the variables have the values described herein. Pharmaceutical formulations include the organic compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier and may be prepared by mixing the organic compounds or pharmaceutically acceptable salts of the organic compounds with a carrier and water. A method of treating a patient includes administering a pharmaceutical formulation according to the invention to a patient in need thereof.

L'invention concerne des composés organiques ayant les formules (I et II) dans lesquelles les variables ont les valeurs décrites dans la description. L'invention concerne également des formulations pharmaceutiques contenant les composés organiques ou leur sel pharmaceutiquement acceptable ainsi qu'un excipient pharmaceutiquement acceptable pouvant être préparées par mélange des composés organiques ou de sels pharmaceutiquement acceptables des composés organiques avec un excipient et de l'eau. L'invention concerne également une méthode de traitement d'un patient consistant à administrer une formulation pharmaceutique selon l'invention à un patient la nécessitant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quinolinone derivatives as tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolinone derivatives as tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolinone derivatives as tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1699382

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.